We are live on ! Find out more
PJP icon

Invesco Pharmaceuticals ETF

122 hedge funds and large institutions have $154M invested in Invesco Pharmaceuticals ETF in 2026 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 33 increasing their positions, 21 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,525% more capital inflows, than outflows

Capital inflows: $93.8M | Capital outflows: $5.78M

131% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 13

57% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 21

26.9% more ownership

Funds ownership: 22.56% → 49.47% (+27%)

13% more funds holding

Funds holding: 108 → 122 (+14)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $259K

Holders
122
Holders Change
+14
Holders Change %
+12.96%
% of All Funds
1.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
30
Increased
33
Reduced
21
Closed
13
Calls
–
Puts
$259K
Net Calls
-$259K
Net Calls Change
-$259K

PJP Hedge Fund Activity: Q1 2026 in Review

122 of the 8,241 institutional investors tracked by Wall St. Rank reported a position in Invesco Pharmaceuticals ETF (PJP) for Q1 2026, worth a combined $154M — up 118% from $71M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new PJP positions and 13 closed out — a net gain of 17 holders — while 33 added to existing stakes and 21 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $24.4M. The largest seller was FIG Financial Advisory Services, exiting entirely with an estimated $1.54M sold.

  • 122 institutional investors held Invesco Pharmaceuticals ETF (PJP) as of Q1 2026, up from 108 in Q4 2025.
  • Funds reported $154M of Invesco Pharmaceuticals ETF stock for Q1 2026, up 118% quarter-over-quarter.
  • 30 funds opened new Invesco Pharmaceuticals ETF positions in Q1 2026 and 13 closed out, a net change of +17 holders.
  • The largest Invesco Pharmaceuticals ETF buyer in Q1 2026 was Morgan Stanley, an estimated $24.4M added.
  • The largest Invesco Pharmaceuticals ETF seller in Q1 2026 was FIG Financial Advisory Services, an estimated $1.54M sold.

Based on aggregated 13F filings for Q1 2026.